https://pkcsignaling.com/deter....mining-a-digital-wel
The transformants had been screened with polymerase sequence reaction and Western blot analyses. Enzyme-linked immunosorbent assay (ELISA) confirmed the binding of the purified anti-HER2 VHH-FcK towards the HER2-positive cancer of the breast mobile line, SK-BR-3. Migration assay results confirmed anticancer activity for the plant-derived anticancer camelid solitary string antibody. Taken together, we verified the possibility of utilizing anti-HER2 VHH-FcK as a therapeutic anticancer broker, that could be
Like
Comment
Share
